Page last updated: 2024-08-16

vesnarinone and fluorouracil

vesnarinone has been researched along with fluorouracil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Begum, NM; Kuribayashi, N; Miyamoto, Y; Nagai, H; Onoue, T; Tamatani, T; Tomizuka, Y; Uchida, D1

Other Studies

3 other study(ies) available for vesnarinone and fluorouracil

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.
    Molecular cancer, 2009, Aug-12, Volume: 8

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cisplatin; Down-Regulation; Flow Cytometry; Fluorouracil; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Kruppel-Like Transcription Factors; Luciferases; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Pyrazines; Quinolines; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tumor Burden; Xenograft Model Antitumor Assays

2009